AQ-280

N/A

Report date: 2025/05/14 17:22:01
NME

Base Information

Drug NameAQ-280
Drug Alias NameAQ-280
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK1
Therapy Area/IndicationsEosinophilic Esophagitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAqilion AB
China Registration ClassN/A

Develop Information

Active CompaniesAqilion AB
Inactive CompaniesN/A
Active IndicationsEosinophilic Esophagitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A